Hepatitis in 2010: the dawn of a new era in HCV therapy
- PMID: 21293503
- DOI: 10.1038/nrgastro.2010.219
Hepatitis in 2010: the dawn of a new era in HCV therapy
Abstract
Although several antiviral treatments for HBV infection have recently reached the market, no direct acting antiviral drugs to treat infection with HCV have been licensed in the 20 years since its identification. Excitingly, recent publications herald several small revolutions in antiviral treatment of HCV that have considerable relevance for prospective HCV therapies.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
